Insider Transactions in Q1 2025 at Black Diamond Therapeutics, Inc. (BDTX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2025
|
Ali Behbahani |
BUY
Grant, award, or other acquisition
|
Direct |
7,646
+9.72%
|
$7,646
$1.88 P/Share
|
|
Mar 21
2025
|
Prakash Raman |
BUY
Grant, award, or other acquisition
|
Direct |
6,848
+28.72%
|
$6,848
$1.88 P/Share
|
|
Mar 19
2025
|
Growth N V Biotech > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,784,292
-14.57%
|
$11,568,584
$2.07 P/Share
|
|
Jan 30
2025
|
Brent Hatzis Schoch |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+47.35%
|
-
|
|
Jan 30
2025
|
Erika Jones |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+46.83%
|
-
|
|
Jan 30
2025
|
Elizabeth Buck CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+30.59%
|
-
|
|
Jan 30
2025
|
Sergey Yurasov CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+50.0%
|
-
|
|
Jan 30
2025
|
Mark A. Velleca PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+38.16%
|
-
|